May 06, 2020 / 06:30AM GMT
Operator
Good morning, and welcome to this first quarter 2020 presentation for PCI Biotech. My name is Per Walday, and I'm the CEO of PCI Biotech. I have with me also Ronny Skuggedal, who is the CFO for PCI Biotech.
We will start this presentation that due to the COVID-19 pandemic is only done through a webcast this time, by going through the background of the company, a bit on the technology, then some highlights for the quarter and then a more detailed look into the different programs and to end up when -- with the outlook. And we will open up -- we are opening up also for questions now from the webcast, and you can start submitting questions already now if you want to do that.
So let's move into the presentation and to start to talk a little bit about PCI Biotech, what we are.
So we are a company -- biotech company, developing technology that was invented at the Radium Hospital. It's called photochemical internalization. That's why it's called PCI Biotech. Photochemical internalization is a platform technology that can be used for a number of different applications. We are focusing
Q1 2020 PCI Biotech Holding ASA Earnings Call Transcript
May 06, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers